Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion type Assertion NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_head.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion description "[When considered together with the established role of E2F3 in cell cycle progression, these results suggest that the E2F3 gene represents a candidate bladder cancer oncogene that is activated by DNA amplification and overexpression.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_provenance.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion evidence source_evidence_literature NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_provenance.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion SIO_000772 14716298 NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_provenance.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion wasDerivedFrom befree-20140225 NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_provenance.
- NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_assertion wasGeneratedBy ECO_0000203 NP355809.RAoLXXOio4S1iO7nyAPv2OI8G9azIYu3253l8SjUus2qE130_provenance.